175
panel
Global Asset Management in Transition: Innovation, Risk, and the Road Ahead
The global asset management sector is undergoing a fundamental shift in strategy as firms adapt
to persistent market volatility, interest rate uncertainty, and heightened political and regulatory uncertainty.
+ Read More
panel
How South-South Investments are Accelerating the Rise of the Rest
As the world gradually shifts from a unipolar toward a multipolar geopolitical order, the Global
South is assuming a broader functional role across economic, diplomatic, and strategic arenas.
+ Read More
panel
The Asia Pacific Investment Outlook
panel
The New World Order of Biomedical Innovation
For decades, substantial public investment—particularly in nations such as the United States and
Singapore—has driven biomedical research.
+ Read More
panel
Asia Summit Check-in
panel
Closing Plenary
video
Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Some Possible Solutions
The growing prevalence of antimicrobial resistance (AMR) around the world poses a serious challeng
e to our health and well-being, including the health systems we all rely on for our care.
+ Read More
video
Dec. 7 at 4:30 pm ET | Is Digital Health a Bridge to Health Equity and Representation?
Systemic health-care inequities exposed by the COVID-19 pandemic included minority under-represent
ation in research and disparities in care.
+ Read More
video
Dec. 7 at 4:30 pm ET | The Silent Patient at Work: How Employers Are Doing More for Substance Use Disorders and Mental Health
The CDC reported a record 93,000 overdose deaths in the US in 2020. Though addiction may yield to
COVID-19 in the news, this grim number tells that the addiction crisis rages on, exacerbated by the effects of necessary social distancing measures.
+ Read More
video
Dec. 7 at 4 pm ET | A Conversation with FDA Acting Commissioner Janet Woodcock
Moderator
Margaret (Peggy) Hamburg
video
Dec. 7 at 2:30 pm ET | A Conversation with US Representatives Diana DeGette and Fred Upton on Cures 2.0 Legislation
Moderator
Meg Tirrell
Biotech and Pharma Reporter, CNBC